Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $81.93 | $24.27 | 237.54% | 154.58x | 39.37x | 10.39x | 12.55x | 1.13x | $106.92M | 1.24% | $705.78M | 6.70 | $8.75B | 1,115.98 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $32.00 | $8.38 | 282.08% | 152.38x | 73.43x | 9.00x | 18.23x | 1.30x | $39.15M | 0.94% | $220.58M | 1.69 | $4.10B | 90.36 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $313.52 | $74.80 | 319.13% | 118.31x | 32.63x | 24.66x | 6.52x | 1.51x | $90.43M | 1.44% | $961.76M | 48.18 | $7.37B | 74.82 | ||
| HALO | HALOZYME THERAPEUTICS INC | $128.62 | $72.10 | 78.40% | 36.13x | 14.27x | 9.07x | 101.70x | 0.70x | $806.22M | 5.35% | $143.54M | 1.22 | $16.58B | 23.08 | ||
| RPRX | ROYALTY PHARMA PLC | $66.40 | $37.12 | 78.90% | 35.32x | 12.24x | 11.65x | 3.90x | 0.71x | $2.92B | 9.89% | $9.79B | 21.99 | $46.33B | 39.39 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.66 | $19.82 | 180.79% | 146.47x | 25.17x | 3.16x | 1.70x | 0.93x | $738.18M | 6.86% | $6.32B | 32.68 | $14.09B | 36.52 | ||
| KRYS | KRYSTAL BIOTECH INC | $305.03 | $77.81 | 292.03% | 39.82x | 40.67x | 19.22x | 6.30x | 2.20x | $310.08M | 3.43% | $1.44B | 48.48 | $8.58B | 32.33 | ||
| VCEL | VERICEL CORP | $41.09 | $8.15 | 404.30% | 85.60x | 72.91x | 6.85x | 5.69x | 2.10x | $61.66M | 2.94% | $370.04M | 7.25 | $2.07B | 47.02 | ||
| TGTX | TG THERAPEUTICS INC | $60.75 | $22.83 | 166.15% | 19.72x | 59.26x | 10.77x | 15.39x | 2.20x | $17.39M | 0.20% | $604.08M | 4.26 | $9.57B | 68.73 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $229.74 | $130.11 | 76.57% | 63.12x | 15.19x | 3.15x | 3.52x | 0.61x | $1.65B | 11.12% | $4.19B | 64.79 | $18.34B | 16.00 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $93.29 | $14.70 | 534.55% | 65.24x | 71.87x | 7.71x | 10.32x | 3.52x | $197.20M | 2.70% | $710.19M | 9.08 | $7.26B | 47.73 | ||
| ADMA | ADMA BIOLOGICS INC | $11.11 | $7.11 | 56.32% | 15.43x | 13.96x | 4.95x | 6.10x | 0.90x | $116.47M | 4.59% | $408.21M | 1.79 | $2.55B | 10.95 | ||
| INCY | INCYTE CORP | $117.59 | $54.09 | 117.38% | 56.26x | 35.04x | 3.98x | 4.25x | 0.80x | $684.87M | 2.87% | $5.64B | 27.76 | $20.72B | 23.10 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.26 | $7.75 | 32.35% | 10.80x | 9.43x | 4.46x | 2.80x | 0.94x | $82.01M | 13.51% | $217.65M | 3.68 | $465.45M | 6.02 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $530.76 | $150.75 | 252.09% | 30.63x | 27.70x | 10.70x | 6.64x | 2.31x | $3.80B | 2.82% | $20.25B | 79.81 | $130.36B | 23.69 | ||
| EXEL | EXELIXIS INC | $72.31 | $32.09 | 125.34% | 20.96x | 20.97x | 7.15x | 9.62x | 1.37x | $1.16B | 6.51% | $1.83B | 7.43 | $17.50B | 15.66 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $973.36 | $462.91 | 110.27% | 20.71x | 15.13x | 5.86x | 3.01x | 1.21x | $3.83B | 3.87% | $33.50B | 329.39 | $99.74B | 15.97 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.02 | $31.62 | 17.08% | 11.79x | 8.93x | 2.23x | 2.16x | 0.66x | $354.90M | 16.55% | $999.24M | 17.25 | $1.76B | 6.29 | ||
| UTHR | UNITED THERAPEUTICS CORP | $601.32 | $207.04 | 190.44% | 19.88x | 22.05x | 8.12x | 4.03x | 2.80x | $1.09B | 4.27% | $6.40B | 150.24 | $23.99B | 14.31 | ||
| TECH | BIO-TECHNE CORP | $72.66 | $16.61 | 337.51% | 62.10x | 34.97x | 9.33x | 5.40x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.42B | 32.84 | ||
| VCYT | VERACYTE INC | $50.29 | $12.14 | 314.22% | 34.92x | 25.93x | 7.16x | 2.91x | 2.82x | $165.99M | 4.13% | $1.39B | 17.36 | $3.78B | 27.07 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.